Delayed cell cycle progression in selenoprotein w-depleted cells is regulated by a mitogen-activated protein kinase kinase 4-p38/c-Jun NH 2-terminal kinase-p53 pathway

Journal of Biological Chemistry

Volumn 287, Issue 33, 2012, Pages 27371-27379

  Hawkes, Wayne Chris ^a   Alkan, Zeynep ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL-CYCLE ARREST; CELL-CYCLE PROGRESSION; EPITHELIAL CELLS; MITOGEN-ACTIVATED PROTEIN KINASE KINASE; NUCLEAR ACCUMULATION; SELENOPROTEINS; UBIQUITINATION;

CELLS; ENZYME ACTIVITY; PHOSPHORYLATION;

CYTOLOGY;

MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE KINASE 6; MITOGEN ACTIVATED PROTEIN KINASE KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 DELTA; MITOGEN ACTIVATED PROTEIN KINASE P38 GAMMA; PROTEIN P53; SELENOPROTEIN W; SERINE; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ARTICLE; BIOACCUMULATION; CELL CYCLE REGULATION; CELL NUCLEUS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; ENZYME STABILITY; G1 PHASE CELL CYCLE CHECKPOINT; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ACTIVE TRANSPORT, CELL NUCLEUS; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL NUCLEUS; G1 PHASE; GENE SILENCING; HUMANS; MALE; MAP KINASE KINASE 4; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 12; MITOGEN-ACTIVATED PROTEIN KINASE 13; MITOGEN-ACTIVATED PROTEIN KINASE 9; PHOSPHORYLATION; SELENOPROTEIN W; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84865016316     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.346593     Document Type: Article

References (67)

1. Hawkes, W. C., Wang, T. T., Alkan, Z., Richter, B. D., and Dawson, K. (2009) Selenoprotein W modulates control of cell cycle entry. Biol. Trace Elem. Res. 131, 229-244
2. Hawkes, W. C., and Alkan, Z. (2011) Delayed cell cycle progression from SEPW1 depletion is p53- and p21-dependent in MCF-7 breast cancer cells. Biochem. Biophys. Res. Commun. 413, 36-40
3. Hawkes, W. C., Printsev, I., and Alkan, Z. (2012) Selenoprotein W depletion induces a p53- and p21-dependent delay in cell cycle progression in RWPE-1 prostate epithelial cells. J. Cell Biochem. 113, 61-69
4. Wu, G. S. (2004) The functional interactions between the p53 and MAPK signaling pathways. Cancer Biol. Ther. 3, 156-161
5. Whitmarsh, A. J., and Davis, R. J. (2007) Role of mitogen-activated protein kinase kinase 4 in cancer. Oncogene 26, 3172-3184 (Pubitemid 46763013)
6. Salmeron, A., Ahmad, T. B., Carlile, G. W., Pappin, D., Narsimhan, R. P., and Ley, S. C. (1996) Activation of MEK-1 and SEK-1 by Tpl-2 proto-oncoprotein, a novel MAP kinase kinase kinase. EMBO J. 15, 817-826
7. Takeda, K., Hatai, T., Hamazaki, T. S., Nishitoh, H., Saitoh, M., and Ichijo, H. (2000) Apoptosis signal-regulating kinase 1 (ASK1) induces neuronal differentiation and survival of PC12 cells. J. Biol. Chem. 275, 9805-9813 (Pubitemid 30185216)
8. Szmulewitz, R. Z., Clark, R., Lotan, T., Otto, K., Taylor Veneris, J., Macleod, K., and Rinker-Schaeffer, C. (2012) MKK4 suppresses metastatic colonization by multiple highly metastatic prostate cancer cell lines through a transient impairment in cell cycle progression. Int. J. Cancer 130, 509-520
9. Swat, W., Fujikawa, K., Ganiatsas, S., Yang, D., Xavier, R. J., Harris, N. L., Davidson, L., Ferrini, R., Davis, R. J., Labow, M. A., Flavell, R. A., Zon, L. I., and Alt, F. W. (1998) SEK1/MKK4 is required for maintenance of a normal peripheral lymphoid compartment but not for lymphocyte development. Immunity 8, 625-634 (Pubitemid 28264753)
10. Nishina, H., Vaz, C., Billia, P., Nghiem, M., Sasaki, T., De la Pompa, J. L., Furlonger, K., Paige, C., Hui, C., Fischer, K. D., Kishimoto, H., Iwatsubo, T., Katada, T., Woodgett, J. R., and Penninger, J. M. (1999) Defective liver formation and liver cell apoptosis in mice lacking the stress signaling kinase SEK1/MKK4. Development 126, 505-516 (Pubitemid 29082037)
11. Cunningham, S. C., Gallmeier, E., and Kern, S. E. (2010) MKK4 as oncogene or tumor suppressor. In cancer and senescence, the story's getting old. Aging 2, 752-753
12. Taylor, J. K. (1987) Quality Assurance of Chemical Measurements, p. 24, Lewis Publishers, Chelsea, MI
13. Hu, M. C., Qiu, W. R., and Wang, Y. P. (1997) JNK1, JNK2, and JNK3 are p53 N-terminal serine 34 kinases. Oncogene 15, 2277-2287 (Pubitemid 27496979)
14. Kishi, H., Nakagawa, K., Matsumoto, M., Suga, M., Ando, M., Taya, Y., and Yamaizumi, M. (2001) Osmotic shock induces G1 arrest through p53 phosphorylation at Ser-33 by activated p38MAPK without phosphorylation at Ser-15 and Ser-20. J. Biol. Chem. 276, 39115-39122
15. O'Brate, A., and Giannakakou, P. (2003) The importance of p53 location. Nuclear or cytoplasmic zip code? Drug Resist. Updat. 6, 313-322 (Pubitemid 38173582)
16. Spillman, M. A., Lacy, J., Murphy, S. K., Whitaker, R. S., Grace, L., Teaberry, V., Marks, J. R., and Berchuck, A. (2007) Regulation of the metastasis suppressor gene MKK4 in ovarian cancer. Gynecol. Oncol. 105, 312-320 (Pubitemid 46590321)
17. Robinson, V. L., Shalhav, O., Otto, K., Kawai, T., Gorospe, M., and Rinker-Schaeffer, C. W. (2008) Mitogen-activated protein kinase kinase 4/c-Jun NH2-terminal kinase kinase 1 protein expression is subject to translational regulation in prostate cancer cell lines. Mol. Cancer Res. 6, 501-508 (Pubitemid 351416540)
18. Davis, R. J. (2000) Signal transduction by the JNK group of MAP kinases. Cell 103, 239-252
19. Nuntharatanapong, N., Chen, K., Sinhaseni, P., and Keaney, J. F., Jr. (2005) EGF receptor-dependent JNK activation is involved in arsenite-induced p21Cip1/Waf1 up-regulation and endothelial apoptosis. Am. J. Physiol. Heart Circ. Physiol. 289, H99-H107 (Pubitemid 40934087)
20. Fuchs, S. Y., Adler, V., Pincus, M. R., and Ronai, Z. (1998) MEKK1/JNK signaling stabilizes and activates p53. Proc. Natl. Acad. Sci. U.S.A. 95, 10541-10546 (Pubitemid 28413103)
21. Bardeleben, R., Kaina, B., and Fritz, G. (2003) Ultraviolet light-induced apoptotic death is impaired by the HMG-CoA reductase inhibitor lovastatin. Biochem. Biophys. Res. Commun. 307, 401-407 (Pubitemid 36818885)
22. Almeida, E. A., Ili, D., Han, Q., Hauck, C. R., Jin, F., Kawakatsu, H., Schlaepfer, D. D., and Damsky, C. H. (2000) Matrix survival signaling. From fibronectin via focal adhesion kinase to c-Jun NH2-terminal kinase. J. Cell Biol. 149, 741-754 (Pubitemid 30252406)
23. Diener, K., Wang, X. S., Chen, C., Meyer, C. F., Keesler, G., Zukowski, M., Tan, T. H., and Yao, Z. (1997) Activation of the c-Jun N-terminal kinase pathway by a novel protein kinase related to human germinal center kinase. Proc. Natl. Acad. Sci. U.S.A. 94, 9687-9692 (Pubitemid 27408124)
24. Takeda, K., Shimozono, R., Noguchi, T., Umeda, T., Morimoto, Y., Naguro, I., Tobiume, K., Saitoh, M., Matsuzawa, A., and Ichijo, H. (2007) Apoptosis signal-regulating kinase 2 (ASK2) functions as a mitogen-activated protein kinase kinase kinase in a heteromeric complex with ASK1. J. Biol. Chem. 282, 7522-7531 (Pubitemid 47093697)
25. Hirai, S., Katoh, M., Terada, M., Kyriakis, J. M., Zon, L. I., Rana, A., Avruch, J., and Ohno, S. (1997) MST/MLK2, a member of the mixed lineage kinase family, directly phosphorylates and activates SEK1, an activator of c-Jun N-terminal kinase/stress-activated protein kinase. J. Biol. Chem. 272, 15167-15173 (Pubitemid 27255532)
26. Cheng, J., Yang, J., Xia, Y., Karin, M., and Su, B. (2000) Synergistic interaction of MEK kinase 2, c-Jun N-terminal kinase (JNK) kinase 2, and JNK1 results in efficient and specific JNK1 activation. Mol. Cell. Biol. 20, 2334-2342 (Pubitemid 30152041)
27. Hershko, T., Korotayev, K., Polager, S., and Ginsberg, D. (2006) E2F1 modulates p38 MAPK phosphorylation via transcriptional regulation of ASK1 and Wip1. J. Biol. Chem. 281, 31309-31316 (Pubitemid 46041395)
28. Boehme, K. A., and Blattner, C. (2009) Regulation of p53. Insights into a complex process. Crit. Rev. Biochem. Mol. Biol. 44, 367-392
29. Lin, A., Minden, A., Martinetto, H., Claret, F. X., Lange-Carter, C., Mercurio, F., Johnson, G. L., and Karin, M. (1995) Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2. Science 268, 286-290
30. Ambrosino, C., and Nebreda, A. R. (2001) Cell cycle regulation by p38 MAP kinases. Biol. Cell 93, 47-51 (Pubitemid 33040859)
31. Molnár, A., Theodoras, A. M., Zon, L. I., and Kyriakis, J. M. (1997) Cdc42Hs, but not Rac1, inhibits serum-stimulated cell cycle progression at G1/S through a mechanism requiring p38/RK. J. Biol. Chem. 272, 13229-13235
32. Song, L., Dai, T., Xiong, H., Lin, C., Lin, H., Shi, T., and Li, J. (2010) Inhibition of centriole duplication by centrobin depletion leads to p38-p53-mediated cell cycle arrest. Cell. Signal. 22, 857-864
33. Mikule, K., Delaval, B., Kaldis, P., Jurcyzk, A., Hergert, P., and Doxsey, S. (2007) Loss of centrosome integrity induces p38-p53-p21-dependent G1-S arrest. Nat. Cell Biol. 9, 160-170 (Pubitemid 46420858)
34. Todd, D. E., Densham, R. M., Molton, S. A., Balmanno, K., Newson, C., Weston, C. R., Garner, A. P., Scott, L., and Cook, S. J. (2004) ERK1/2 and p38 cooperate to induce a p21CIP1-dependent G1 cell cycle arrest. Oncogene 23, 3284-3295 (Pubitemid 38669818)
35. Lafarga, V., Cuadrado, A., Lopez de Silanes, I., Bengoechea, R., Fernandez-Capetillo, O., and Nebreda, A. R. (2009) p38 mitogen-activated protein kinase- and HuR-dependent stabilization of p21(Cip1) mRNA mediates the G1/S checkpoint. Mol. Cell. Biol. 29, 4341-4351
36. Bode, A. M., and Dong, Z. (2004) Post-translational modification of p53 in tumorigenesis. Nat. Rev. Cancer 4, 793-805 (Pubitemid 39331151)
37. She, Q. B., Ma, W. Y., and Dong, Z. (2002) Role of MAP kinases in UVB-induced phosphorylation of p53 at serine 20. Oncogene 21, 1580-1589
38. Fuchs, S. Y., Adler, V., Buschmann, T., Yin, Z., Wu, X., Jones, S. N., and Ronai, Z. (1998) JNK targets p53 ubiquitination and degradation in non-stressed cells. Genes Dev. 12, 2658-2663 (Pubitemid 28420646)
39. Topisirovic, I., Gutierrez, G. J., Chen, M., Appella, E., Borden, K. L., and Ronai, Z. A. (2009) Control of p53 multimerization by Ubc13 is JNK-regulated. Proc. Natl. Acad. Sci. U.S.A. 106, 12676-12681
40. Dhanasekaran, D. N., and Reddy, E. P. (2008) JNK signaling in apoptosis. Oncogene 27, 6245-6251
41. Ria, R., Todoerti, K., Berardi, S., Coluccia, A. M., De Luisi, A., Mattioli, M., Ronchetti, D., Morabito, F., Guarini, A., Petrucci, M. T., Dammacco, F., Ribatti, D., Neri, A., and Vacca, A. (2009) Gene expression profiling of bone marrow endothelial cells in patients with multiple myeloma. Clin. Cancer Res. 15, 5369-5378
42. Blüher, M., Bashan, N., Shai, I., Harman-Boehm, I., Tarnovscki, T., Avinaoch, E., Stumvoll, M., Dietrich, A., Klöting, N., and Rudich, A. (2009) Activated Ask1-MKK4-p38MAPK/JNK stress signaling pathway in human omental fat tissue may link macrophage infiltration to whole-body Insulin sensitivity. J. Clin. Endocrinol. Metab. 94, 2507-2515
43. Wagner, E. F., and Nebreda, A. R. (2009) Signal integration by JNK and p38 MAPK pathways in cancer development. Nat. Rev. Cancer 9, 537-549
44. Schwacke, J. H., and Voit, E. O. (2007) The potential for signal integration and processing in interacting MAP kinase cascades. J. Theor. Biol. 246, 604-620 (Pubitemid 46719256)
45. Yu, Y., and Richardson, D. R. (2011) Cellular iron depletion stimulates the JNK and p38 MAPK signaling transduction pathways, dissociation of ASK1-thioredoxin, and activation of ASK1. J. Biol. Chem. 286, 15413-15427
46. Nguyen, H. T., Hsieh, M. H., Gaborro, A., Tinloy, B., Phillips, C., and Adam, R. M. (2006) JNK/SAPK and p38 SAPK-2 mediate mechanical stretch-induced apoptosis via caspase-3 and -9 in NRK-52E renal epithelial cells. Nephron. Exp. Nephrol. 102, e49-61 (Pubitemid 43087566)
47. Benhar, M., Dalyot, I., Engelberg, D., and Levitzki, A. (2001) Enhanced ROS production in oncogenically transformed cells potentiates c-Jun Nterminal kinase and p38 mitogen-activated protein kinase activation and sensitization to genotoxic stress. Mol. Cell. Biol. 21, 6913-6926 (Pubitemid 32911252)
48. Saito, S., Yamaguchi, H., Higashimoto, Y., Chao, C., Xu, Y., Fornace, A. J., Jr., Appella, E., and Anderson, C. W. (2003) Phosphorylation site interdependence of human p53 post-translational modifications in response to stress. J. Biol. Chem. 278, 37536-37544 (Pubitemid 37175275)
49. Aachmann, F. L., Fomenko, D. E., Soragni, A., Gladyshev, V. N., and Dikiy, A. (2007) Solution structure of selenoprotein W and NMR analysis of its interaction with 14-3-3 proteins. J. Biol. Chem. 282, 37036-37044
50. Dikiy, A., Novoselov, S. V., Fomenko, D. E., Sengupta, A., Carlson, B. A., Cerny, R. L., Ginalski, K., Grishin, N. V., Hatfield, D. L., and Gladyshev, V. N. (2007) SelT, SelW, SelH, and Rdx12. Genomics and molecular insights into the functions of selenoproteins of a novel thioredoxin-like family. Biochemistry 46, 6871-6882 (Pubitemid 46906416)
51. Lee, J. H., and Lu, H. (2011) 14-3-3γ inhibition of MDMX-mediated p21 turnover independent of p53. J. Biol. Chem. 286, 5136-5142
52. Wang, B., Liu, K., Lin, F. T., and Lin, W. C. (2004) A role for 14-3-3 tau in E2F1 stabilization and DNA damage-induced apoptosis. J. Biol. Chem. 279, 54140-54152 (Pubitemid 40053150)
53. Yang, H. Y., Wen, Y. Y., Chen, C. H., Lozano, G., and Lee, M. H. (2003) 14-3-3δ positively regulates p53 and suppresses tumor growth. Mol. Cell. Biol. 23, 7096-7107 (Pubitemid 37210993)
54. Zuo, S., Xue, Y., Tang, S., Yao, J., Du, R., Yang, P., and Chen, X. (2010) 14-3-3ε dynamically interacts with key components of mitogen-activated protein kinase signal module for selective modulation of the TNF-α-induced time course-dependent NF-κB activity. J. Proteome Res. 9, 3465-3478
55. Fanger, G. R., Widmann, C., Porter, A. C., Sather, S., Johnson, G. L., and Vaillancourt, R. R. (1998) 14-3-3 proteins interact with specific MEK kinases. J. Biol. Chem. 273, 3476-3483 (Pubitemid 28109768)
56. Zheng, Q., Yin, G., Yan, C., Cavet, M., and Berk, B. C. (2004) 14-3-3β binds to big mitogen-activated protein kinase 1 (BMK1/ERK5) and regulates BMK1 function. J. Biol. Chem. 279, 8787-8791 (Pubitemid 38295936)
57. Johnson, C., Crowther, S., Stafford, M. J., Campbell, D. G., Toth, R., and MacKintosh, C. (2010) Bioinformatic and experimental survey of 14-3-3-binding sites. Biochem. J. 427, 69-78
58. Zhang, H., Zhang, R., Zhang, H., Lin, Y., Li, J., Pober, J. S., and Min, W. (2007) RIP1-mediated AIP1 phosphorylation at a 14-3-3-binding site is critical for tumor necrosis factor-induced ASK1-JNK/p38 activation. J. Biol. Chem. 282, 14788-14796 (Pubitemid 47093366)
59. Zhang, S., Ren, J., Zhang, C. E., Treskov, I., Wang, Y., and Muslin, A. J. (2003) Role of 14-3-3-mediated p38 mitogen-activated protein kinase inhibition in cardiac myocyte survival. Circ. Res. 93, 1026-1028 (Pubitemid 37485032)
60. Xing, H., Zhang, S., Weinheimer, C., Kovacs, A., and Muslin, A. J. (2000) 14-3-3 proteins block apoptosis and differentially regulate MAPK cascades. EMBO J. 19, 349-358 (Pubitemid 30072605)
61. Johnson, C., Tinti, M., Wood, N. T., Campbell, D. G., Toth, R., Dubois, F., Geraghty, K. M., Wong, B. H., Brown, L. J., Tyler, J., Gernez, A., Chen, S., Synowsky, S., and MacKintosh, C. (2011) Visualization and biochemical analyses of the emerging mammalian 14-3-3-phosphoproteome. Mol. Cell. Proteomics 10, 1-15
62. Bruckmann, A., Hensbergen, P. J., Balog, C. I., Deelder, A. M., de Steensma, H. Y., and van Heusden, G. P. (2007) Post-transcriptional control of the Saccharomyces cerevisiae proteome by 14-3-3 proteins. J. Proteome Res. 6, 1689-1699 (Pubitemid 46814493)
63. Wilker, E. W., van Vugt, M. A., Artim, S. A., Huang, P. H., Petersen, C. P., Reinhardt, H. C., Feng, Y., Sharp, P. A., Sonenberg, N., White, F. M., and Yaffe, M. B. (2007) 14-3-3δ controls mitotic translation to facilitate cytokinesis. Nature 446, 329-332 (Pubitemid 46426148)
64. McGonigle, S., Beall, M. J., and Pearce, E. J. (2002) Eukaryotic initiation factor 2 α-subunit associates with TGFβ receptors and 14-3-3ε and acts as a modulator of the TGFβ response. Biochemistry 41, 579-587 (Pubitemid 34062028)
65. Larance, M., Rowland, A. F., Hoehn, K. L., Humphreys, D. T., Preiss, T., Guilhaus, M., and James, D. E. (2010) Global phosphoproteomics identifies a major role for AKT and 14-3-3 in regulating EDC3. Mol. Cell. Proteomics 9, 682-694
66. Ge, W. W., Volkening, K., Leystra-Lantz, C., Jaffe, H., and Strong, M. J. (2007) 14-3-3 protein binds to the low molecular weight neurofilament (NFL) mRNA 3′-UTR. Mol. Cell. Neurosci. 34, 80-87 (Pubitemid 46026930)
67. Zhong, L., and Holmgren, A. (2000) Essential role of selenium in the catalytic activities of mammalian thioredoxin reductase revealed by characterization of recombinant enzymes with selenocysteine mutations. J. Biol. Chem. 275, 18121-18128 (Pubitemid 30414762)